The National Institutes of Health is sunsetting its influential COVID-19 treatment guidelines, used by millions of doctors to guide care during the pandemic. Accessibility links.

Researchers have described the optimal timing for COVID-19 patients to take the antiviral, Paxlovid, to get the most benefit from the treatment, according to a study published April 16 in eLife.

COVID-19 is caused by the SARS-CoV-2 virus. ... Paxlovid is the leading COVID-19 treatment, but is currently only recommended for people who are considered at risk of severe disease.

COVID-19 cases are rising in more than half of states. Is the US in a summer wave? What to know about COVID trends and ...

Paxlovid is an antiviral combination therapy that can reduce the risk of COVID-19 causing severe illness, hospitalization and ...

No improvement in clinical outcomes occurred among inpatients with COVID-19 who received nirtmatrelvir-ritonavir or molnupiravir in addition to usual care.

“Some people think that if they got the vaccine or feel healthy, they don’t need treatment,” said Karyne Jones, President and CEO of NCBA, Inc. and co-convener of CVEEP. “But that’s not always true.

The Front Line COVID-19 Critical Care Alliance (FLCCC) lists about 20 medications, vitamins and therapies as part of its "i-recover" protocol for long COVID-19, with ivermectin at the top of the list.

In 2020, then-President Donald Trump said he had been taking hydroxychloroquine to prevent a COVID-19 infection, despite warnings by the U.S. Food and Drug Administration over its effectiveness.

He had heard of a new coronavirus treatment -- like the one President Donald Trump was given during his bout with COVID-19. The treatment of lab-created monoclonal antibodies is meant to be used ...